Sep 22, 2009 | Zacks Analyst Blog
Inhibitex Initiated at Neutral
Analyst Report ) with a 'Neutral' rating and $2 price target. Our neutral rating stems from the very early-stage nature of the company's pipeline -- leading candidate FV-100 is currently in phase II testing -- and the potential dilution risk coming from cash-raising activities later in 2009 or in 2010.
Column: Cold sores might be prevented, not cured
If you've ever had a cold sore, you know that they can be quite painful -- and visible.
DRUG NEWS POSTHERPETIC NEURALGIA Oxycodone eases acute shingles pain Although patients with herpes zoster can suffer severe acute pain for several weeks, little research has been done on effective oral treatments.
Acyclovir, Famciclovir & Valacyclovir
Antiviral medications have proven clinical effectiveness against genital herpes.
Treating the Cold Sore, Not Just the Symptoms
Published Online: September 1, 2007 - 12:00:00 AM This article is brought to you by GlaxoSmithKline.
Though the herpes virus is thought to remain in the body forever once a person is infected, there are several treatments that can ease symptoms and/or reduce future outbreaks.
Also on Topix